Cargando…
SARS-CoV-2–infected primary human airway epithelia illustrate mucus hypersecretion
Autores principales: | Posch, Wilfried, Lass-Flörl, Cornelia, Wilflingseder, Doris |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285928/ https://www.ncbi.nlm.nih.gov/pubmed/34284045 http://dx.doi.org/10.1016/j.jaci.2021.05.047 |
Ejemplares similares
-
ColdZyme® protects airway epithelia from infection with BA.4/5
por: Viktoria, Zaderer, et al.
Publicado: (2022) -
Correction: ColdZyme® protects airway epithelia from infection with BA.4/5
por: Zaderer, Viktoria, et al.
Publicado: (2023) -
ColdZyme Maintains Integrity in SARS-CoV-2-Infected Airway Epithelia
por: Posch, W., et al.
Publicado: (2021) -
Omicron subvariants illustrate reduced respiratory tissue penetration, cell damage and inflammatory responses in human airway epithelia
por: Zaderer, Viktoria, et al.
Publicado: (2023) -
C5aR inhibition of nonimmune cells suppresses inflammation and maintains epithelial integrity in SARS-CoV-2–infected primary human airway epithelia
por: Posch, Wilfried, et al.
Publicado: (2021)